The immunophenotypic diagnosis of CLL relies on the identification of CD5+CD3−CD23+CD20low light chain-restricted lymphocytes in the blood or bone marrow of affected patients. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.